Sernova (TSE:SVA) Hits New 12-Month Low at $0.28

Sernova Corp. (TSE:SVA)’s stock price reached a new 52-week low during trading on Thursday . The company traded as low as C$0.28 and last traded at C$0.28, with a volume of 114250 shares trading hands. The stock had previously closed at C$0.30.

Wall Street Analyst Weigh In

Separately, Raymond James set a C$1.50 target price on Sernova and gave the company a “market perform” rating in a research report on Thursday, April 4th.

Sernova Price Performance

The company has a current ratio of 1.20, a quick ratio of 18.11 and a debt-to-equity ratio of 16.55. The stock has a market cap of C$87.99 million, a PE ratio of -2.27 and a beta of 1.53. The company has a fifty day moving average of C$0.34 and a 200-day moving average of C$0.50.

Sernova (TSE:SVA) last posted its quarterly earnings data on Friday, June 14th. The company reported C($0.03) earnings per share (EPS) for the quarter, meeting the consensus estimate of C($0.03). Sell-side analysts expect that Sernova Corp. will post -0.08 EPS for the current fiscal year.

About Sernova

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.